Activation of the 12/15 lipoxygenase pathway accompanies metabolic decline in db/db pre-diabetic mice.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Prostaglandins & other lipid mediators

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.prostaglandins.2018.03.003PMID 29605541
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Baicalein improves liver inflammation in diabetic db/db mice by regulating HMGB1/TLR4/NF‐&kgr;B signaling pathway

  2018cited by this paper
• 12-Lipoxygenase Inhibitor Improves Functions of Cytokine-Treated Human Islets and Type 2 Diabetic Islets

  2017cited by this paper
• The double-edged role of 12/15-lipoxygenase during inflammation and immunity.

  2017cited by this paper
• ERV1 Overexpression in Myeloid Cells Protects against High Fat Diet Induced Obesity and Glucose Intolerance

  2017cited by this paper
• Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes

  2017cited by this paper
• Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunction

  2015cited by this paper
• Minireview: 12-Lipoxygenase and Islet β-Cell Dysfunction in Diabetes.

  2015cited by this paper
• Expression pattern of 12-lipoxygenase in human islets with type 1 diabetes and type 2 diabetes.

  2015cited by this paper
• The role of lipoxygenases in pathophysiology; new insights and future perspectives

  2015cited by this paper
• Pro-resolving lipid mediators are leads for resolution physiology

  2014cited by this paper
• Synthesis and Structure − Activity Relationship Studies of 4 ‐ ( ( 2-Hydroxy-3-methoxybenzyl ) amino ) benzenesulfonamide Derivatives as Potent and Selective Inhibitors of 12-Lipoxygenase

  2014cited by this paper
• Adipose tissue 12/15 lipoxygenase pathway in human obesity and diabetes.

  2014cited by this paper
• Potent and Selective Inhibitors of Human Reticulocyte 12/15-Lipoxygenase as Anti-Stroke Therapies

  2014cited by this paper
• 12-Lipoxygenase Promotes Obesity-Induced Oxidative Stress in Pancreatic Islets

  2014cited by this paper
• 12- and 15-lipoxygenases in adipose tissue inflammation.

  2013cited by this paper
• Type 2 diabetes mellitus—an autoimmune disease?

  2013cited by this paper
• Islet inflammation: a unifying target for diabetes treatment?

  2013cited by this paper
• Diversity of lipid mediators in human adipose tissue depots.

  2013cited by this paper
• Interaction between cytokines and inflammatory cells in islet dysfunction, insulin resistance and vascular disease

  2013cited by this paper
• The use of animal models in diabetes research

  2012cited by this paper
• 12/15-Lipoxygenase signaling in the endoplasmic reticulum stress response.

  2012cited by this paper
• Adipose Tissue-Specific Deletion of 12/15-Lipoxygenase Protects Mice from the Consequences of a High-Fat Diet

  2012cited by this paper
• Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.

  2011cited by this paper
• Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats.

  2011cited by this paper
• Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice.

  2011cited by this paper
• Functional and pathological roles of the 12- and 15-lipoxygenases.

  2011cited by this paper
• Selective Small Molecule Inhibitors of 12-Human Lipoxygenase (12-hLO)

  2011cited by this paper
• Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling.

  2010cited by this paper
• 12-Lipoxygenase Products Reduce Insulin Secretion and {beta}-Cell Viability in Human Islets.

  2010cited by this paper
• Differential expression and localization of 12/15 lipoxygenases in adipose tissue in human obese subjects.

  2010cited by this paper
• Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1.

  2010cited by this paper
• Lipocalin-2 Deficiency Attenuates Insulin Resistance Associated With Aging and Obesity

  2010cited by this paper
• 12/15‐Lipoxygenase Products Induce Inflammation and Impair Insulin Signaling in 3T3‐L1 Adipocytes

  2009cited by this paper
• 12/15-Lipoxygenase Is Required for the Early Onset of High Fat Diet-Induced Adipose Tissue Inflammation and Insulin Resistance in Mice

  2009cited by this paper
• beta-Cell-specific overexpression of glutathione peroxidase preserves intranuclear MafA and reverses diabetes in db/db mice.

  2009cited by this paper
• Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions

  2009cited by this paper
• Dual 12/15- and 5-Lipoxygenase Deficiency in Macrophages Alters Arachidonic Acid Metabolism and Attenuates Peritonitis and Atherosclerosis in ApoE Knock-out Mice*

  2009cited by this paper
• Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

  2008cited by this paper
• 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet.

  2008cited by this paper
• Substrate specificity changes for human reticulocyte and epithelial 15-lipoxygenases reveal allosteric product regulation.

  2008cited by this paper
• Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries.

  2007cited by this paper
• Increased Number of Islet-Associated Macrophages in Type 2 Diabetes

  2007cited by this paper
• Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases.

  2006cited by this paper
• Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity

  2005cited by this paper
• Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500294-JLR200

  2005cited by this paper
• Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase

  2004cited by this paper
• Obesity is associated with macrophage accumulation in adipose tissue.

  2003cited by this paper
• Kinetic investigations of the rate-limiting step in human 12- and 15-lipoxygenase.

  2003cited by this paper
• Phenotypes of Mouse diabetes and Rat fatty Due to Mutations in the OB (Leptin) Receptor

  1996cited by this paper
• cDNA cloning, expression, mutagenesis of C-terminal isoleucine, genomic structure, and chromosomal localizations of murine 12-lipoxygenases.

  1994cited by this paper
• The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. V. Interaction between the db gene and hepatic sex steroid sulfotransferases correlates with gender-dependent susceptibility to hyperglycemia.

  1989cited by this paper
• The genetics of diabetes susceptibility in mice

  1989cited by this paper
• Genetic Control of Organ-Reactive Autoantibody Production in Mice by Obesity (ob) Diabetes (db) Genes

  1988cited by this paper
• Effect of immunodeficiency on diabetogenesis in genetically diabetic (db/db) mice.

  1987cited by this paper
• Influence of dietary carbohydrate on the induction of diabetes in C57BL/KsJ-db/db diabetes mice.

  1983cited by this paper

• Sargassum fusiforme Fucoidan Ameliorates Obesity-Associated Metabolic Dysfunction via a Tauroursodeoxycholic Acid-Mediated TGR5-cAMP-PKA Signaling Pathway.

  2025cites this paper
• The Dysregulation of Essential Fatty Acid (EFA) Metabolism May Be a Factor in the Pathogenesis of Sepsis

  2024cites this paper
• Membrane Lipid Derivatives: Roles of Arachidonic Acid and Its Metabolites in Pancreatic Physiology and Pathophysiology

  2023cites this paper
• A review on the relationship between Arachidonic acid 15-Lipoxygenase (ALOX15) and diabetes mellitus

  2023cites this paper
• 12(S)‐hydroxyeicosatetraenoic acid is significantly increased in diabetic kidney disease and associated with renal function decline

  2022cites this paper
• The multifaceted role of cytochrome P450-Derived arachidonic acid metabolites in diabetes and diabetic cardiomyopathy

  2022cites this paper
• Effects of Arachidonic Acid and Its Metabolites on Functional Beta-Cell Mass

  2022cites this paper
• 12/15-Lipoxygenase Regulation of Diabetic Cognitive Dysfunction Is Determined by Interfering with Inflammation and Cell Apoptosis

  2022cites this paper
• Roles of hydroxyeicosatetraenoic acids in diabetes (HETEs and diabetes).

  2022cites this paper
• A 12‐lipoxygenase‐Gpr31 signaling axis is required for pancreatic organogenesis in the zebrafish

  2020cites this paper
• The emerging role of COX-2, 15-LOX, and PPARγ in metabolic diseases and cancer: An introduction to novel multi-target directed ligands (MTDLs).

  2020cites this paper
• 5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease

  2020cites this paper
• Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies.

  2019cites this paper
• Role of the 12‐lipoxygenase pathway in diabetes pathogenesis and complications

  2019cites this paper